Today (26 July), the European Union’s drugs regulator, the Committee for Medicinal Products for Human Use (CHMP), has advised that the drug lecanemab, a treatment for Alzheimer’s disease, should not be approved for use in the EU.

New figures from the NHS show that record numbers of people are being diagnosed with dementia in England.

A survey by Alzheimer’s Society reveals 88% of people affected by dementia have not contacted a dementia charity for support.

The Football Association (FA) and Alzheimer’s Society have today announced a further extension to its charity partnership until July 2025. 

Our Director of Research responds to news that the FDA has approved new Alzheimer's disease drug donanemab in the US.

UK dementia organisations have joined forces to publish a new dementia manifesto ahead of the General Election on 4 July 2024.